CD47 and neoplasm: To this end, we compared the immune cell populations in the TDLNs of the mice that were tumor-free - responders (CD47−/− 3BD9 R), and those that developed tumors after vaccination - non-responders (CD47−/− 3BD9 NR) (Supplementary Table 2).